Vascular adhesion protein-1 and syndecan-1 in septic shock

Acta Anaesthesiologica Scandinavica

Volumn 56, Issue 3, 2012, Pages 316-322

  Sallisalmi, M ^a   Tenhunen, J ^b   Yang, R ^b   Oksala, N ^c   Pettila V ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; SYNDECAN 1; VASCULAR ADHESION PROTEIN 1;

ABDOMINAL INFECTION; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; ENDOCARDITIS; ENZYME ACTIVITY; FEMALE; HUMAN; LABORATORY TEST; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; MENINGITIS; PNEUMONIA; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SEPTIC SHOCK; SOFT TISSUE INFECTION; THROMBOCYTE COUNT;

ADULT; AGED; AMINE OXIDASE (COPPER-CONTAINING); BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CRITICAL ILLNESS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOCALYX; HUMANS; INFECTION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SHOCK, SEPTIC; SYNDECAN-1;

EID: 84857239745     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2011.02578.x     Document Type: Article

References (45)

1. Jalkanen S, Salmi M,. VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler Thromb Vasc Biol 2008; 28: 18-26.
2. Stolen CM, Yegutkin GG, Kurkijarvi R, Bono P, Alitalo K, Jalkanen S,. Origins of serum semicarbazide-sensitive amine oxidase. Circ Res 2004; 95: 50-57. (Pubitemid 38931835)
3. Salmi M, Jalkanen S,. Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 2005; 5: 760-771. (Pubitemid 41400850)
4. Koskinen K, Vainio PJ, Smith DJ, Pihlavisto M, Yla-Herttuala S, Jalkanen S, Salmi M,. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1). Blood 2004; 103: 3388-3395. (Pubitemid 38525669)
5. Tohka S, Laukkanen M, Jalkanen S, Salmi M,. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. FASEB J 2001; 15: 373-382. (Pubitemid 32141429)
6. Merinen M, Irjala H, Salmi M, Jaakkola I, Hanninen A, Jalkanen S,. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol 2005; 166: 793-800. (Pubitemid 40315636)
7. Salter-Cid LM, Wang E, O'Rourke AM, Miller A, Gao H, Huang L, Garcia A, Linnik MD,. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase. J Pharmacol Exp Ther 2005; 315: 553-562. (Pubitemid 41500719)
8. Weinbaum S, Tarbell JM, Damiano ER,. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007; 9: 121-167. (Pubitemid 350246654)
9. Chappell D, Dorfler N, Jacob M, Rehm M, Welsch U, Conzen P, Becker BF,. Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion. Shock 2010; 34: 133-139.
10. Chappell D, Hofmann-Kiefer K, Jacob M, Rehm M, Briegel J, Welsch U, Conzen P, Becker BF,. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 2009; 104: 78-89.
11. Chappell D, Jacob M, Hofmann-Kiefer K, Bruegger D, Rehm M, Conzen P, Welsch U, Becker BF,. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007; 107: 776-784. (Pubitemid 351325970)
12. Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JB, Kastelein JJ, Stroes ES, Vink H,. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006; 55: 1127-1132. (Pubitemid 44100191)
13. Steppan J, Hofer S, Funke B, Brenner T, Henrich M, Martin E, Weitz J, Hofmann U, Weigand MA,. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. J Surg Res 2011; 165: 136-141.
14. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL,. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32: 1825-1831. (Pubitemid 39202356)
15. Trzeciak S, McCoy JV, Phillip Dellinger R, Arnold RC, Rizzuto M, Abate NL, Shapiro NI, Parrillo JE, Hollenberg SM, Microcirculatory Alterations in Resuscitation and Shock (MARS) investigators. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008; 34: 2210-2217.
16. Cabrales P, Vazquez BY, Tsai AG, Intaglietta M,. Microvascular and capillary perfusion following glycocalyx degradation. J Appl Physiol 2007; 102: 2251-2259. (Pubitemid 47080757)
17. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G,. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256. (Pubitemid 36444440)
18. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG,. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710.
19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE,. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829. (Pubitemid 15250137)
20. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, Peter K, Becker BF,. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116: 1896-1906. (Pubitemid 350287085)
21. Lin MS, Li HY, Wei JN, Lin CH, Smith DJ, Vainio J, Shih SR, Chen YH, Lin LC, Kao HL, Chuang LM, Chen MF,. Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease. Clin Biochem 2008; 41: 1362-1367.
22. Kurkijarvi R, Adams DH, Leino R, Mottonen T, Jalkanen S, Salmi M,. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol 1998; 161: 1549-1557. (Pubitemid 28380589)
23. Kurkijarvi R, Yegutkin GG, Gunson BK, Jalkanen S, Salmi M, Adams DH,. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology 2000; 119: 1096-1103.
24. Abella A, Garcia-Vicente S, Viguerie N, Ros-Baro A, Camps M, Palacin M, Zorzano A, Marti L,. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 2004; 47: 429-438. (Pubitemid 38491239)
25. Salmi M, Stolen C, Jousilahti P, Yegutkin GG, Tapanainen P, Janatuinen T, Knip M, Jalkanen S, Salomaa V,. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. Am J Pathol 2002; 161: 2255-2262. (Pubitemid 35434869)
26. Li HY, Wei JN, Lin MS, Smith DJ, Vainio J, Lin CH, Chiang FT, Shih SR, Huang CH, Wu MY, Hsein YC, Chuang LM,. Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia. Clin Chim Acta 2009; 404: 149-153.
27. Jalkanen S, Karikoski M, Mercier N, Koskinen K, Henttinen T, Elima K, Salmivirta K, Salmi M,. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood 2007; 110: 1864-1870. (Pubitemid 47443898)
28. Lalor PF, Sun PJ, Weston CJ, Martin-Santos A, Wakelam MJ, Adams DH,. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion. Hepatology 2007; 45: 465-474. (Pubitemid 46374603)
29. Stolen CM, Marttila-Ichihara F, Koskinen K, Yegutkin GG, Turja R, Bono P, Skurnik M, Hanninen A, Jalkanen S, Salmi M,. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity 2005; 22: 105-115. (Pubitemid 40143455)
30. Kiss J, Jalkanen S, Fulop F, Savunen T, Salmi M,. Ischemia-reperfusion injury is attenuated in VAP-1-deficient mice and by VAP-1 inhibitors. Eur J Immunol 2008; 38: 3041-3049.
31. Bonaiuto E, Lunelli M, Scarpa M, Vettor R, Milan G, Di Paolo ML,. A structure-activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme. Biochimie 2010; 92: 858-868.
32. Yu PH, Lai CT, Zuo DM,. Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem Res 1997; 22: 615-620. (Pubitemid 27184691)
33. Shimokawa H,. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pflugers Arch 2010; 459: 915-922.
34. Yu PH, Wright S, Fan EH, Lun ZR, Gubisne-Harberle D,. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta 2003; 1647: 193-199. (Pubitemid 38234655)
35. Elliott J, Callingham BA, Sharman DF,. Semicarbazide-sensitive amine oxidase (SSAO) of the rat aorta. Interactions with some naturally occurring amines and their structural analogues. Biochem Pharmacol 1989; 38: 1507-1515. (Pubitemid 19123342)
36. Nunes SF, Figueiredo IV, Pereira JS, Teixeira de Lemos E, Reis F, Teixeira F, Caramona MM,. Monoamine oxidase and semicarbazide-sensitive amine oxidase kinetic analysis in mesenteric arteries of patients with type 2 diabetes. Physiol Res 2011; 60: 309-315.
37. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M,. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 2008; 30: 623-627.
38. Fitzgerald ML, Wang Z, Park PW, Murphy G, Bernfield M,. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol 2000; 148: 811-824.
39. Svennevig K, Hoel T, Thiara A, Kolset S, Castelheim A, Mollnes T, Brosstad F, Fosse E, Svennevig J,. Syndecan-1 plasma levels during coronary artery bypass surgery with and without cardiopulmonary bypass. Perfusion 2008; 23: 165-171.
40. Hayashida K, Chen Y, Bartlett AH, Park PW,. Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock. J Biol Chem 2008; 283: 19895-19903.
41. Hayashida K, Parks WC, Park PW,. Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood 2009; 114: 3033-3043.
42. Haynes A 3rd, Ruda F, Oliver J, Hamood AN, Griswold JA, Park PW, Rumbaugh KP,. Syndecan 1 shedding contributes to Pseudomonas aeruginosa sepsis. Infect Immun 2005; 73: 7914-7921. (Pubitemid 41740275)
43. Broekhuizen LN, Mooij HL, Kastelein JJ, Stroes ES, Vink H, Nieuwdorp M,. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. Curr Opin Lipidol 2009; 20: 57-62.
44. Levick JR, Michel CC,. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010; 87: 198-210.
45. Vainio PJ, Kortekangas-Savolainen O, Mikkola JH, Jaakkola K, Kalimo K, Jalkanen S, Veromaa T,. Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis. Basic Clin Pharmacol Toxicol 2005; 96: 429-435. (Pubitemid 40835697)